COMPANY INFO
Navina Technologies Ltd. is a healthcare software company founded in 2018 by Ronen Lavi and Shay Perera. With approximately 165-177 employees, Navina develops an AI-driven platform that restructures complex patient data into intuitive patient portraits, enabling clinicians to make better diagnoses and provide personalized, proactive care. The company’s website is www.navina.ai, and it operates primarily in the healthcare AI and software industry.
Navina Technologies Ltd. is a healthcare software company founded in 2018 by Ronen Lavi and Shay Perera. Specializing in AI-driven solutions, Navina builds an advanced platform that restructures complex patient data into intuitive patient portraits, empowering clinicians to make more informed diagnoses and deliver personalized, proactive care. Employing over 165 professionals, Navina operates at the forefront of healthcare AI and software innovation.
Navina Technologies Ltd. funding history illustrates a strong growth trajectory backed by a strategic investment approach. The company has raised a total of $100 million over four funding rounds, enabling it to scale its platform capabilities, accelerate adoption among U.S. physician groups, and further invest in proprietary AI technology. Navina’s funding rounds highlight key milestones, such as expanding its footprint in the U.S. healthcare market and enhancing its clinical AI algorithms, with participation from leading venture capital and strategic healthcare investors.
Navina’s most recent Series C round raised $55 million, led by Goldman Sachs Alternatives Growth Equity. The capital is targeted at expanding Navina’s reach across the U.S. healthcare market, further developing its proprietary AI technology, and improving patient outcomes.
The Series B funding round secured $22 million with ALIVE Israel HealthTech Fund leading the investment. This round aimed to accelerate Navina’s growth, drive adoption among physician groups across the U.S., and invest in AI-driven clinical algorithms.
Navina closed an undisclosed Series A round led by Vertex Ventures Israel. This capital was used to advance the company’s AI technology and broaden its user base in the healthcare industry.
Navina’s seed round brought in $7 million, led by Grove Ventures. The primary aim was to fund the initial launch of Navina’s platform and support early product development.
Goldman Sachs Asset Management, through its Alternatives Growth Equity arm, led Navina’s Series C round. As a global leader in investment management, Goldman Sachs brings significant expertise and resources to support Navina’s nationwide U.S. expansion and technological advancements.
A prominent investor dedicated to healthcare technology, the ALIVE Israel Healthtech Fund led Navina’s Series B round and provided essential support for the company’s growth and product adoption strategy in key healthcare markets.
Schusterman Family Investments brings a strategic, long-term perspective to Navina’s investor pool, leveraging experience in healthcare and technology ventures to support the company’s mission and expansion.
As lead investor in the Series A round, Vertex Ventures Israel played a pivotal role in advancing Navina’s AI capabilities and scaling its platform to a broader user base within the healthcare sector.
Grove Ventures led Navina’s seed funding, supporting the company's initial launch and product development with expertise in early-stage growth for groundbreaking technology companies.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Navina Technologies Ltd. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.